Theriva Biologics, Inc. - Common stock (TOVX)

CUSIP: 87164U508

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common stock
Shares outstanding
9,600,143
Total 13F shares
291,012
Share change
+100,331
Total reported value
$126,275
Price per share
$0.43
Number of holders
15
Value change
+$38,331
Number of buys
9
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 87164U508?
CUSIP 87164U508 identifies TOVX - Theriva Biologics, Inc. - Common stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of TOVX - Theriva Biologics, Inc. - Common stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
CVI Investments, Inc.
13D/G
—
4.9%
146,136
 $206,052 $0 31 Dec 2024
13D/G
Ikarian Capital, LLC
13F
Company
1.3%
120,031
 $132,034 — 31 Mar 2025
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.37%
35,601
 $39,161 — 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.19%
18,683
 $20,554 — 31 Mar 2025
13F
UBS Group AG
13F
Company
0.08%
7,851
 $8,636 — 31 Mar 2025
13F
BlackRock, Inc.
13F
Company
0.08%
7,568
 $8,325 — 31 Mar 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
0.01%
884
 $972 — 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
41
 $45 — 31 Mar 2025
13F
IFP Advisors, Inc
13F
Company
0%
11
 $12 — 31 Mar 2025
13F
SBI Securities Co., Ltd.
13F
Company
0%
10
 $11 — 31 Mar 2025
13F
DANSKE BANK A/S
13F
Company
0%
1
 $1 — 31 Mar 2025
13F
Francis Tufaro
3/4/5
Chief Operating Officer —
class O/S missing
100,000
 — — 15 Dec 2022
3/4/5

Institutional Holders of Theriva Biologics, Inc. - Common stock (TOVX) as of Q2 2025

As of 30 Jun 2025, Theriva Biologics, Inc. - Common stock (TOVX) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 291,012 shares. The largest 10 holders included Ikarian Capital, LLC, CITADEL ADVISORS LLC, BOOTHBAY FUND MANAGEMENT, LLC, Virtu Financial LLC, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA SECURITIES, LLC, XTX Topco Ltd, BlackRock, Inc., FMR LLC, and OSAIC HOLDINGS, INC.. This page lists 15 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
10
Q2 2025 holders
15
Holder diff
5
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .